20.40PLN-0.49%Mkt Cap: 1.10B PLNP/E: 10.00Last update: 2026-06-01
Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes,…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap1.10B PLN
Enterprise Value1.15B PLN
Revenue (TTM)225.60M PLN
Gross Profit154.13M PLN
Net Income (TTM)-79.36M PLN
Revenue/Share4.335 PLN
Last Price20.40 PLN
Fiscal Year EndDec 2024
MR QuarterMar 2026
Employees553
CountryPL
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINPLCLNPH00015
Valuation
P/E (Trailing)10.00
P/E (Forward)12.81
PEG—
EV/EBITDA-13.36
EV/Revenue5.09
P/S4.89
P/B2.48
EPS (TTM)2.04
EPS (Forward)1.60
52W Range
18.5028% of range25.30
52W High25.30 PLN
52W Low18.50 PLN
Profitability
Gross Margin68.32%
Oper. Margin-9.66%
EBITDA Margin-38.14%
Profit Margin-54.25%
ROE-21.85%
ROA-17.35%
Growth
Revenue Growth26.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF23.85M PLN
CapEx (TTM)—
FCF Margin-34.02%
FCF Yield-6.99%
Net Debt45.33M PLN
Net Debt/EBITDA-0.53
Balance Sheet
Debt/Equity10.15
Current Ratio1.90
Quick Ratio1.38
Book Value/Sh8.267 PLN
Cash/Share0.1550 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield0.68%
Payout Ratio0.00%
Ex-Div DateJun 27, 2024
Pay Date—
Analyst Consensus
Rating3.4 (Hold)
Target (Mean)20.44 PLN
Target Range16.00 PLN – 25.50 PLN
# Analysts5
Ownership
Shares Out.53.86M
Float23.83M
Insiders55.75%
Institutions18.03%
Technical
SMA 5020.81 (-1.9%)
SMA 20021.53 (-5.3%)
Beta0.72
S&P 52W Chg27.94%
Avg Vol (30d)8.59K
Avg Vol (10d)7.79K
Technical Indicators
RSI (14)39.0
MACD-0.0678
MACD Signal-0.0325
MACD Hist.-0.0353
BB Upper21.56 PLN
BB Middle21.00 PLN
BB Lower20.44 PLN
BB Width5.36%
ATR (14)0.5171 PLN
Vol Ratio (20d)1.11x